BIOMAT Database Logo BIOMAT Database Logo

Fluphenazine enanthate for the difficult psychotic patient. 1969

A R Stewart, and B Lavallee

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010259 Paranoid Disorders Chronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system (persecutory delusions or delusions of jealousy), accompanied by preservation of clear and orderly thinking. Emotional responses and behavior are consistent with the delusional state. Paranoia,Paranoid Psychoses,Psychoses, Paranoid,Disorder, Paranoid,Disorders, Paranoid,Paranoias,Paranoid Disorder
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D001925 Brain Damage, Chronic A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions. Encephalopathy, Chronic,Chronic Encephalopathy,Chronic Brain Damage
D005260 Female Females
D005476 Fluphenazine A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE. Flufenazin,Fluphenazine Hydrochloride,Lyogen,Prolixin,Hydrochloride, Fluphenazine

Related Publications

A R Stewart, and B Lavallee
Fluphenazine enanthate in the treatment of psychotic patients.
June 1966, International journal of neuropsychiatry,
A R Stewart, and B Lavallee
The use of fluphenazine enanthate in psychotic patients.
March 1973, Current therapeutic research, clinical and experimental,
A R Stewart, and B Lavallee
Acute psychotic episodes in patients treated with fluphenazine enanthate.
November 1969, The British journal of psychiatry : the journal of mental science,
A R Stewart, and B Lavallee
[Fluphenazine enanthate].
September 1966, Revista brasileira de medicina,
A R Stewart, and B Lavallee
A controlled comparative study of fluphenazine and fluphenazine enanthate in acute and chronic psychotic patients.
January 1970, Psychiatria, neurologia, neurochirurgia,
A R Stewart, and B Lavallee
Fluphenazine enanthate: a report of a clinical trial in psychotic patients.
April 1968, Current therapeutic research, clinical and experimental,
A R Stewart, and B Lavallee
Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
January 1978, Neuropsychobiology,
A R Stewart, and B Lavallee
Fluphenazine enanthate in the treatment of chronic psychotic patients: a controlled clinical study.
February 1971, Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology,
A R Stewart, and B Lavallee
Fluphenazine enanthate induced decompensations.
January 1975, Psychosomatics,
A R Stewart, and B Lavallee
Fluphenazine enanthate in schizophrenia.
August 1970, British medical journal,
Copied contents to your clipboard!